A16G (p.Ala16Gly) variant of CR1 (Complement receptor type 1)

A16G (p.Ala16Gly) in CR1 (Complement receptor type 1) is a missense change. The available variant effect predictions contribute to a CATVariant prioritization score of 0.08 / 1. The record also includes population frequency data, published literature, and structural context.

A16G (p.Ala16Gly) variant details